Back to Results
First PageMeta Content
Health / Spinal muscular atrophy / SMN1 / Mipomersen / Survival of motor neuron / Duchenne muscular dystrophy / Amyotrophic lateral sclerosis / Atrophy / Muscular dystrophy / Motor neurone disease / Genetic genealogy / Medical genetics


ISIS INITIATES PHASE 1 CLINICAL STUDY OF ISIS-SMNRX IN PATIENTS WITH SPINAL MUSCULAR ATROPHY U.S. FDA has granted both Fast Track Status and Orphan Drug Designation for ISIS-SMNRx CARLSBAD, Calif., December 19, 2011 –
Add to Reading List

Document Date: 2013-04-29 02:31:35


Open Document

File Size: 137,73 KB

Share Result on Facebook
UPDATE